Tempus announces six posters accepted for presentation at ispor 2025

Chicago--(business wire)--tempus ai, inc. (nasdaq: tem), a technology company leading the adoption of ai to advance precision medicine and patient care, has announced the presentation of six posters, including one oral presentation, at the 2025 annual meeting of the professional society for health economics and outcomes research (ispor), taking place may 13-16 in montreal, canada. tempus researchers are showcasing scientific and clinical studies highlighting the impact of ai and real-world data.
TEM Ratings Summary
TEM Quant Ranking